Alpenglow Biosciences, the leader in clinical-grade 3D digital pathology and AI-powered spatial analytics, and PathNet, one ...

Alpenglow Biosciences announced a partnership with PathNet to help commercialize use of the startup's 3D microscope ...

Fox Chase Cancer Center and Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that ...

A two-meter aluminum sculpture, the base in Vesuvian stone and wise eyes, designed to recall the ability of the great ...

If vitamin C stops cancer in its tracks, and being deficient in it can cause scurvy — the disease long associated with ...

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites ...

For decades, autism research compared autistic people to animals, denied them moral sensitivity, and assumed autistic traits ...

New study links ketogenic diet to improved PCOS outcomes Could the ketogenic diet—a regimen known for rapid weight loss—help ...

But cell and gene therapies (CGTs) are catching up. During Cell and Gene Therapy International Europe 2025, held in Berlin, ...

CORA Loyalty, the loyalty portfolio arm of CORA Group ("CORA"), advises financial institutions to move beyond product-based rewards and adopt enterprise loyalty strategies that recognize and reward ...

NEW YORK — Alpenglow Biosciences has partnered with digital pathology lab PathNet to develop 3D pathology-based diagnostics for prostate and bladder cancers, the companies said on Thursday.

Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation AwardExpands iNKT platform into ...